News
A safety panel of the European drug regulator on Friday recommended adding a rare spinal inflammation called transverse myelitis as a side effect of AstraZeneca's COVID-19 vaccine.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback